One of the many challenges with existing HIV therapies is that a dormant version of the virus is always lurking in the background, ready to attack the immune system as soon as treatment is interrupted. Now, new research suggests that treatment with two anti-HIV antibodies immediately after infection enables the immune system to effectively control the virus, preventing its return for an extended period.

View the source article